Snehasikta Swarnakar | Biochemistry | Best Researcher Award

Prof. Snehasikta Swarnakar | Biochemistry | Best Researcher Award

University of Calcutta- India

Author Profile

Early Academic Pursuits 📚

Dr. (Miss) Snehasikta Swarnakar’s academic journey began with a strong foundation in chemistry, physics, and mathematics during her Bachelor’s degree at Calcutta University from 1980 to 1983. Her academic curiosity and drive for excellence propelled her into a diverse educational path, culminating in an MSc in Biochemistry with a special paper on Advanced Microbiology from Calcutta University (1985–1987). The thirst for deeper scientific inquiry led her to pursue a Ph.D. from Jadavpur University, Kolkata, from 1988 to 1993. Her doctoral research focused on “Studies on a sialic acid-binding lectin from the albumin gland of apple snail Pila globosa,” which contributed significantly to the understanding of biochemistry and microbiology.

Her educational path also included specialized training in Physical Education (Dip P. Ed), which enriched her holistic approach to science and well-being. This broad spectrum of academic qualifications in chemistry, microbiology, and biochemistry laid the groundwork for her highly successful scientific career. 🧬🔬

Professional Endeavors 💼

Dr. Swarnakar’s professional career has spanned prestigious institutions across the world, making significant contributions to the field of biochemistry, immunology, and infectious diseases. After completing her Ph.D., she joined JNU, New Delhi as a Senior Research Fellow in 1994. This was followed by post-doctoral fellowships at renowned institutions like the University of California, Davis (1994–1997), Marine Biological Laboratory, Woods Hole, USA, and State University of New York, Stony Brook (1997–1999). These positions provided her with global exposure and advanced training in biochemistry and molecular biology.

Dr. Swarnakar returned to India and joined CSIR-Indian Institute of Chemical Biology (CSIR-IICB) in Kolkata in 2002. Here, she climbed the ranks from Scientist-C to Scientist-G, taking on leadership roles. As the Chief Scientist and Head of the P&I Division and Infectious Diseases and Immunity Division, she has led numerous groundbreaking research projects. Her interdisciplinary expertise and leadership have shaped her as a key figure in the scientific community. 🌍💉

Contributions and Research Focus 🔬

Dr. Swarnakar’s research spans the fields of biochemistry, immunology, and infectious diseases, with particular focus on understanding immune responses and developing therapeutic interventions. Her early research on sialic acid-binding lectins, which helped unlock new biochemical mechanisms, laid the foundation for her later work on immunity and infectious diseases.

Her ongoing work includes leading the Infectious Diseases and Immunity Division at CSIR-IICB, where her contributions in the field of vaccine development, immune system understanding, and disease pathology have garnered international attention. Dr. Swarnakar’s collaborations with global institutions, including a Fulbright Fellowship at Emory University, have further expanded her influence in cutting-edge research on immunity and infectious diseases. 🌱🧬

Accolades and Recognition 🏆

Dr. Swarnakar’s work has earned her widespread recognition within the scientific community. She is a Fellow of the National Academy of Sciences (FNASc) and the Academy of Sciences for the Developing World (FAScT). These prestigious honors reflect her contributions to science and her role in advancing research in the fields of immunology and biochemistry. In addition, her career has been marked by numerous fellowships and international collaborations, enhancing her reputation as a leading scientist in her field.

Her recognition is not limited to academic circles; Dr. Swarnakar has also been honored for her leadership and mentorship of young scientists. These accolades attest to her outstanding contributions to science and society. 👩‍🔬💡

Impact and Influence 🌍

Dr. Swarnakar’s impact extends beyond the laboratory. Through her leadership roles, both at CSIR-IICB and in international collaborations, she has influenced the direction of research in immunology, infectious diseases, and vaccine development. Her research has helped enhance our understanding of the immune system, which is crucial for the development of vaccines and therapeutic strategies for combating infectious diseases.

Her work continues to inspire young scientists and researchers, particularly women in science, to pursue careers in biochemistry and immunology. As a mentor and leader, she fosters an environment of scientific inquiry, integrity, and innovation. Dr. Swarnakar’s influence has shaped the scientific landscape in India and abroad. 🌏🔬

Legacy and Future Contributions 🌟

As a trailblazer in her field, Dr. Swarnakar’s legacy is defined by her dedication to research, her pioneering contributions, and her mentorship of the next generation of scientists. Her future contributions are expected to drive advancements in immunology, vaccine research, and infectious diseases. By continuing her interdisciplinary approach and global collaborations, she aims to unlock new therapeutic targets for combating diseases and improving public health.

Her ongoing projects at CSIR-IICB will likely leave a lasting legacy in the scientific community, and her influence will continue to inspire research innovations for many years to come. Dr. Swarnakar’s commitment to bridging the gap between basic science and practical applications in healthcare ensures that her future work will have a lasting impact on global health. 🌱💉.In conclusion, Dr. Snehasikta Swarnakar’s career exemplifies excellence in scientific research, leadership, and mentorship. Her work continues to shape the future of biochemistry, immunology, and infectious disease research, marking her as one of the foremost scientists in her field.

Citations

A total of 5740 citations for his publications, demonstrating the impact and recognition of his research within the academic community.

  • Citations        5740
  • h-index          42
  • i10-index       81

Notable Publications 

  • Melatonin Inhibits AGS Cell Proliferation by Binding to the ATP Binding Site of CDK2 Under Hyperglycemic Conditions
    • Authors: A Chatterjee, T Roy, D Jyothi, VK Mishra, UP Singh, S Swarnakar
    • Journal: Cell Biochemistry and Biophysics
    • Year: 2024.
  • 3-indolyl furanoids as inhibitors of matrix metalloproteinase-9 for prevention of gastric ulcer and other inflammatory diseases
    • Authors: P Jaisankar, S Swarnakar, S Chatterjee, S Verma, M Mandal, …
    • Journal: US Patent 10,590,116
    • Year: 2020.
  • Curcumin regulates expression and activity of matrix metalloproteinases 9 and 2 during prevention and healing of indomethacin-induced gastric ulcer
    • Authors: S Swarnakar, K Ganguly, P Kundu, A Banerjee, P Maity, AV Sharma
    • Journal: Journal of Biological Chemistry
    • Year: 2005.
  • The Plasma-Based Cytolytic System of the American Horseshoe Crab, Limulus polyphemus: Cooperative Interaction of the Sialic Acid-Binding Lectin Limulin and …
    • Authors: S Swarnakar, JP Quigley, PB Armstrong
    • Journal: The Biological Bulletin
    • Year: 1996.
  • Shatavarin-IV, a steroidal saponin from Asparagus racemosus, inhibits cell cycle progression and epithelial-to-mesenchymal transition in AGS cells under hyperglycemic conditions
    • Authors: A Chatterjee, T Roy, VK Mishra, S Swarnakar
    • Journal: Steroids
    • Year: 2024.

OWAIS BHAT | Biochemistry | Best Researcher Award

Assist Prof Dr. OWAIS BHAT | Biochemistry | Best Researcher Award

Central University of Kashmir- India

Author Profile

🧑‍🎓Early Academic Pursuits 

Dr. Owais Mohmad Bhat, M.Sc., Ph.D., began his illustrious academic journey in the picturesque region of Kashmir, India. His passion for life sciences led him to pursue a B.Sc. in Biochemistry, Chemistry, and Zoology from Sri Pratap College, affiliated with the University of Kashmir. During this period, he developed a strong foundation in the biological sciences, which would later be crucial in his research pursuits.Following his undergraduate studies, Dr. Bhat continued his academic journey at the University of Kashmir, where he completed his M.Sc. in Biochemistry from 2005 to 2007. This period was marked by his growing interest in molecular biology and biochemistry, particularly in understanding the biochemical mechanisms underlying various physiological and pathological processes.His academic pursuits eventually led him to one of the most prestigious institutions in India, the Postgraduate Institute of Medical Education and Research (PGIMER) in Chandigarh. Here, Dr. Bhat embarked on his Ph.D. journey in Biochemistry under the guidance of eminent professors, including Prof. Veena Dhawan, Prof. Deepak Kaul, and Dr. N.V. Giridharan. His thesis, titled “To Study the Effect of Terminalia Arjuna on Interleukin-18 Induced Modulation of Peroxisome Proliferator Activated Receptor-γ Transcriptome in Apo E -/- Mice Model of Atherosclerosis,” explored the molecular mechanisms involved in cardiovascular diseases, particularly atherosclerosis, and the potential therapeutic effects of natural compounds.

🧪Professional Endeavors and Research Focus

Dr. Owais Mohmad Bhat’s professional journey is characterized by his dedication to understanding complex biochemical pathways and their implications in human health and disease. After completing his Ph.D., he moved to the United States, where he worked as a Post-Doctoral Researcher in the Department of Comparative Biomedical Sciences at Louisiana State University. Under the mentorship of Professor Yogesh Saini, Dr. Bhat’s research focused on the role of macrophages in respiratory diseases, particularly the impact of altered macrophage populations on immune responses in respiratory airspaces.In 2016, Dr. Bhat joined the Department of Pharmacology and Toxicology at Virginia Commonwealth University as a Post-Doctoral Researcher. Here, he worked under the supervision of Professor Pin-Lan Li, where he delved into the regulation of autophagic flux by lysosome-associated signaling pathways. His research uncovered critical insights into how deficient autophagy in coronary arterial smooth muscle cells (CASMCs) could lead to atherosclerosis, with a particular focus on the role of lysosomal dysfunction in vascular calcification.ince December 2021, Dr. Bhat has been serving as a Scientist-D and Ramalingaswami Fellow at the Department of Biotechnology, School of Life Sciences, Central University of Kashmir. His current research focuses on vascular calcification, particularly the formation and accumulation of calcium phosphate salts within the vascular wall, which is associated with aging, chronic kidney disease, diabetes mellitus, and atherosclerosis. His work explores the role of small membrane-bound bodies, known as matrix vesicles (MVs), and their exosome counterparts in nucleating calcium phosphate crystals, leading to vascular calcification.

🧬Contributions and Research Focus

Dr. Bhat’s research has significantly contributed to our understanding of the molecular mechanisms underlying vascular calcification. His work has demonstrated how lysosomal dysfunction and sphingolipid metabolism play a crucial role in the excretion of exosomes from arterial smooth muscle cells (SMCs), ultimately leading to vascular calcification. His research also highlights the potential therapeutic targets within the mammalian target of rapamycin complex (mTORC) signaling pathways, which could be manipulated to prevent or reverse vascular calcification.In addition to his research on vascular calcification, Dr. Bhat has also contributed to the field of cardiovascular diseases through his studies on the role of sphingolipids, ceramide, and sphingosine-1-phosphate (S1P) in regulating autophagy and exosome secretion. His research has opened new avenues for understanding how these molecules influence the development of calcification in atherosclerotic plaques and arterial walls.

🏆Accolades and Recognition

Dr. Owais Mohmad Bhat’s dedication to his research has not gone unnoticed. He has been awarded the prestigious Ramalingaswami Fellowship by the Department of Biotechnology, Government of India, which recognizes outstanding scientists returning to India to contribute to the country’s scientific research landscape. This fellowship has allowed Dr. Bhat to continue his groundbreaking research at the Central University of Kashmir, where he has secured funding of 113.6 Lakhs for his projects.

🌍Impact and Influence

Dr. Bhat’s work has had a profound impact on the scientific community’s understanding of vascular calcification and its underlying mechanisms. His research has provided valuable insights into potential therapeutic targets for preventing or treating cardiovascular diseases, particularly in populations at high risk, such as those with chronic kidney disease or diabetes.Moreover, as a mentor to four Ph.D. scholars, Dr. Bhat is actively contributing to the next generation of scientists. His guidance and expertise are helping shape the future of biochemistry and molecular biology research in India.

🌟Legacy and Future Contributions

Dr. Owais Mohmad Bhat’s research legacy is one of dedication to unraveling the complexities of human health and disease at the molecular level. His work on vascular calcification and the role of sphingolipids in cardiovascular diseases is paving the way for new therapeutic approaches that could significantly impact public health.As he continues his research at the Central University of Kashmir, Dr. Bhat is poised to make even more significant contributions to the field. His future work is expected to delve deeper into the molecular mechanisms of vascular calcification, potentially leading to new treatments that could prevent the progression of atherosclerosis and other related diseases.In summary, Dr. Owais Mohmad Bhat, M.Sc., Ph.D., is a distinguished scientist whose work is making a lasting impact on the field of biochemistry and molecular biology. His research, mentorship, and dedication to advancing scientific knowledge are contributing to a brighter future for cardiovascular disease treatment and prevention.

Citations

A total of 751 citations for his publications, demonstrating the impact and recognition of his research within the academic community.

  • Citations         751
  • h-index           35
  • i10-index        17

Notable Publications 

  • Title: Contribution of Hepatic Steatosis–Intensified Extracellular Vesicle Release to Aggravated Inflammatory Endothelial Injury in Liver-Specific Asah1 Gene Knockout Mice
    Authors: Yuan, X., Bhat, O.M., Zou, Y., Zhang, Y., Li, P.-L.
    Journal: American Journal of Pathology
    Year: 2023
  • Title: A Review on Anti-Nutritional Factors: Unraveling the Natural Gateways to Human Health
    Authors: Salim, R., Nehvi, I.B., Mir, R.A., Ali, S., Bhat, O.M.
    Journal: Frontiers in Nutrition
    Year: 2023
  • Title: Endothelial Acid Sphingomyelinase Promotes NLRP3 Inflammasome and Neointima Formation during Hypercholesterolemia
    Authors: Yuan, X., Bhat, O.M., Zou, Y., Zhang, Y., Li, P.-L.
    Journal: Journal of Lipid Research
    Year: 2022
  • Title: Impairment of Ceramide-Mediated Endothelial Instant Membrane Resealing During Diabetes Mellitus
    Authors: Chen, Y., Li, G., Bhat, O.M., Zhang, Y., Li, P.-L.
    Journal: Frontiers in Physiology
    Year: 2022
  • Title: Exosome Biogenesis and Lysosome Function Determine Podocyte Exosome Release and Glomerular Inflammatory Response during Hyperhomocysteinemia
    Authors: Huang, D., Li, G., Bhat, O.M., Ritter, J.K., Li, P.-L.
    Journal: American Journal of Pathology
    Year: 2022.